(0.32%) 5 107.75 points
(0.75%) 38 670 points
(0.57%) 17 751 points
(0.06%) $79.00
(-0.34%) $2.03
(0.07%) $2 311.20
(-0.01%) $26.83
(1.78%) $979.70
(-0.16%) $0.931
(-0.60%) $10.93
(-0.24%) $0.796
(0.49%) $91.58
Live Chart Being Loaded With Signals
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use...
Stats | |
---|---|
今日成交量 | 8 373.00 |
平均成交量 | 11 308.00 |
市值 | 69.46M |
EPS | $0 ( 2024-04-19 ) |
下一个收益日期 | ( $0.0400 ) 2024-07-12 |
Last Dividend | $0.900 ( 2022-09-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.39 |
ATR14 | $0.0860 (1.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-22 | Portnoy Mark L. | Buy | 25 000 | Stock Option |
2023-12-22 | Mikulinsky Oleg | Buy | 10 000 | Stock Option |
2023-12-22 | Taymans Jill M | Buy | 10 000 | Stock Option |
2023-12-22 | Portnoy David | Buy | 50 000 | Stock Option |
2023-10-10 | Berger Harold D. | Buy | 5 300 | Stock Option |
INSIDER POWER |
---|
81.81 |
Last 100 transactions |
Buy: 2 158 485 | Sell: 773 682 |
Cryo-Cell International, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Cryo-Cell International, 财务报表
Annual | 2023 |
营收: | $31.34M |
毛利润: | $22.90M (73.07 %) |
EPS: | $-1.140 |
FY | 2023 |
营收: | $31.34M |
毛利润: | $22.90M (73.07 %) |
EPS: | $-1.140 |
FY | 2022 |
营收: | $30.34M |
毛利润: | $21.54M (71.02 %) |
EPS: | $0.330 |
FY | 2021 |
营收: | $28.88M |
毛利润: | $19.90M (68.88 %) |
EPS: | $0.260 |
Financial Reports:
No articles found.
Cryo-Cell International, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.900 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.900 | 2022-09-01 |
Last Dividend | $0.900 | 2022-09-01 |
Next Dividend | $0 | N/A |
Payout Date | 2022-09-09 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.32 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 2.12 | |
Div. Directional Score | 1.037 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
CSBB | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% | |
BABB | Ex Dividend King | 2023-09-27 | Quarterly | 0 | 0.00% | |
SFDL | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
PPBN | Ex Dividend Knight | 2023-08-17 | Quarterly | 0 | 0.00% | |
HRNNF | Ex Dividend Knight | 2023-09-12 | Quarterly | 0 | 0.00% | |
ENBP | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
CMTV | Ex Dividend Knight | 2023-10-12 | Quarterly | 0 | 0.00% | |
UEPEP | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
RSRV | Ex Dividend Junior | 2023-06-06 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.310 | 1.500 | -6.20 | -9.31 | [0 - 0.5] |
returnOnAssetsTTM | -0.158 | 1.200 | -5.26 | -6.31 | [0 - 0.3] |
returnOnEquityTTM | 1.750 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.488 | 0.800 | -2.56 | -2.05 | [1 - 3] |
quickRatioTTM | 0.398 | 0.800 | -2.37 | -1.892 | [0.8 - 2.5] |
cashRatioTTM | 0.0128 | 1.500 | -1.040 | -1.560 | [0.2 - 2] |
debtRatioTTM | 0.187 | -1.500 | 6.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -12.82 | 1.000 | -5.86 | -5.86 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.838 | 2.00 | 9.72 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0972 | 2.00 | -0.0486 | -0.0972 | [0 - 20] |
debtEquityRatioTTM | -1.118 | -1.500 | -4.47 | 6.71 | [0 - 2.5] |
grossProfitMarginTTM | 0.728 | 1.000 | 1.201 | 1.201 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.420 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.599 | 1.000 | 7.78 | 7.78 | [0.2 - 2] |
assetTurnoverTTM | 0.508 | 0.800 | 9.94 | 7.96 | [0.5 - 2] |
Total Score | -0.0519 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7.27 | 1.000 | -0.835 | 0 | [1 - 100] |
returnOnEquityTTM | 1.750 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0972 | 2.00 | -0.0324 | -0.0972 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.838 | 2.00 | 9.72 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0163 | 1.500 | -3.22 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.221 | 1.000 | 6.99 | 0 | [0.1 - 0.5] |
Total Score | 2.12 |
Cryo-Cell International,
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。